Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome

Adam Evans; Michael T. McCurdy; Menachem Weiner; Bledi Zaku; Jonathan H. Chow

doi:10.1016/j.athoracsur.2018.11.047

Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome

Adam Evans, Michael T. McCurdy, Menachem Weiner, Bledi Zaku, Jonathan H. Chow

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Abstract

Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post–cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.

Original language	English
Pages (from-to)	e5-e7
Journal	Annals of Thoracic Surgery
Volume	108
Issue number	1
DOIs	https://doi.org/10.1016/j.athoracsur.2018.11.047
State	Published - Jul 2019

Access to Document

10.1016/j.athoracsur.2018.11.047

Cite this

@article{8cc7b2f350224810a004b6f0b7479ecc,

title = "Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome",

abstract = "Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post–cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.",

author = "Adam Evans and McCurdy, {Michael T.} and Menachem Weiner and Bledi Zaku and Chow, {Jonathan H.}",

note = "Publisher Copyright: {\textcopyright} 2019 The Society of Thoracic Surgeons",

year = "2019",

month = jul,

doi = "10.1016/j.athoracsur.2018.11.047",

language = "English",

volume = "108",

pages = "e5--e7",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome

AU - Evans, Adam

AU - McCurdy, Michael T.

AU - Weiner, Menachem

AU - Zaku, Bledi

AU - Chow, Jonathan H.

PY - 2019/7

Y1 - 2019/7

N2 - Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post–cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.

AB - Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post–cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.

UR - http://www.scopus.com/inward/record.url?scp=85067358256&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2018.11.047

DO - 10.1016/j.athoracsur.2018.11.047

M3 - Article

C2 - 30582924

AN - SCOPUS:85067358256

SN - 0003-4975

VL - 108

SP - e5-e7

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 1

ER -

Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome

Abstract

Access to Document

Fingerprint

Cite this